Ingalls & Snyder LLC has filed its 13F form on November 07, 2025 for Q3 2025 where it was disclosed a total value porftolio of $3.06 Billion distributed in 482 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Corcept Therapeutics Inc with a value of $640M, Microsoft Corp with a value of $100M, Berkshire Hathaway Inc Class B with a value of $89.2M, Williams Companies, Inc. with a value of $89.2M, and Apple Inc. with a value of $89.4M.

Examining the 13F form we can see an increase of $239M in the current position value, from $2.82B to 3.06B.

Ingalls & Snyder LLC is based out at New York, NY

Below you can find more details about Ingalls & Snyder LLC portfolio as well as his latest detailed transactions.

Portfolio value $3.06 Billion
Healthcare: $861 Million
Technology: $388 Million
Financial Services: $360 Million
Energy: $352 Million
Industrials: $219 Million
Communication Services: $215 Million
Consumer Cyclical: $184 Million
Basic Materials: $131 Million
Other: $275 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 482
  • Current Value $3.06 Billion
  • Prior Value $2.82 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 07, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 28 stocks
  • Additional Purchases 86 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 223 stocks
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.